Skip to Content

WARRICK 1670 (Theophylline Extended-Release 300 mg)

Pill with imprint WARRICK 1670 is White, Capsule-shape and has been identified as Theophylline Extended-Release 300 mg. It is supplied by Warrick Pharmaceuticals Corporation.

Theophylline is used in the treatment of asthma, maintenance; asthma, acute; apnea of prematurity and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WARRICK 1670

Theophylline Extended-Release

Imprint:
WARRICK 1670
Strength:
300 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Methylxanthines
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Warrick Pharmaceuticals Corporation
National Drug Code (NDC):
59930-1670

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide